Sanjay Popat

Sanjay Popat

UNVERIFIED PROFILE

Are you Sanjay Popat?   Register this Author

Register author
Sanjay Popat

Sanjay Popat

Publications by authors named "Sanjay Popat"

Are you Sanjay Popat?   Register this Author

100Publications

2732Reads

44Profile Views

Histologically Transformed SCLC From EGFR-Mutant NSCLC: Understanding the Wolf in Sheep's Clothing.

Authors:
Sanjay Popat

J Thorac Oncol 2019 Oct;14(10):1689-1691

The Royal Marsden Hospital, London, United Kingdom; The Institute of Cancer Research, London, United Kingdom; National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2019.07.010DOI Listing
October 2019

Transformation to neuroendocrine carcinoma as a resistance mechanism to lorlatinib.

Lung Cancer 2019 Aug 6;134:117-120. Epub 2019 Jun 6.

Lung Unit, The Royal Marsden Hospital, 203 Fulham Rd, Chelsea, London, SW3 6JJ, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2019.05.025DOI Listing
August 2019

Defining aggressive or early progressing nononcogene-addicted non-small-cell lung cancer: a separate disease entity?

Future Oncol 2019 Apr 13;15(12):1363-1383. Epub 2019 Feb 13.

Boehringer Ingelheim Pharma GmbH & Co, KG, Germany & Institute of Pharmacology, Johannes Gutenberg-University Mainz, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon-2018-0948DOI Listing
April 2019

Hyperprogression with immunotherapy: Is it real?

Authors:
Sanjay Popat

Cancer 2019 Apr 15;125(8):1218-1220. Epub 2019 Feb 15.

Department of Medicine, Royal Marsden Hospital, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31997DOI Listing
April 2019

Targeting angiogenesis for patients with unresectable malignant pleural mesothelioma.

Semin Oncol 2019 Apr 18;46(2):145-154. Epub 2019 Jun 18.

Department of Thoracic and Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2019.06.001DOI Listing
April 2019

Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.

N Engl J Med 2018 11 25;379(21):2027-2039. Epub 2018 Sep 25.

From the University of Colorado Cancer Center, Aurora (D.R.C.); Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine (H.R.K.), Samsung Medical Center (M.-J.A.), and Seoul National University Hospital (D.-W.K.), Seoul, National Cancer Center, Goyang (J.-Y.H.), Seoul National University Bundang Hospital, Seongnam (J.-S.L.), and Chungbuk National University Hospital, Chungbuk National University College of Medicine, Cheongju (K.H.L.) - all in South Korea; National Taiwan University Hospital (J.C.-H.Y.) and the Faculty of Medicine, School of Medicine, National Yang-Ming University (G.-C.C.), Taipei, and the Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung (G.-C.C.) - all in Taiwan; the Ludwig Boltzmann Institute for COPD and Respiratory Epidemiology, Department of Respiratory and Critical Care Medicine, Otto Wagner Hospital, Vienna (M.J.H.); Queen Elizabeth Hospital, Kowloon, Hong Kong (J.Y.-C.L.); Azienda Ospedaliera S. Giuseppe Moscati, Avellino (C.G.), the Scientific Institute of Romagna for the Study and Treatment of Cancer, Meldola (A.D.), Centro di Riferimento Oncologico, Istituto Nazionale Tumori, IRCCS Struttura Operativa Complessa Oncologia Medica A, Aviano (A.B.), Thoracic Medical Oncology, Istituto Nazionale Tumori, IRCCS Fondazione G. Pascale, Naples (A.M.), and the Medical Oncology Unit, University Hospital of Parma, Parma (M.T.) - all in Italy; Complejo Hospitalario Universitario de A Coruña, Coruña (R.G.C.), and Vall d'Hebron University Hospital, Barcelona (E.F.) - both in Spain; the Department of Hematology and Oncology, University Department of Internal Medicine-Oncology, Pius-Hospital Medical Campus, University of Oldenburg, Oldenburg, Germany (F.G.); the Department of Medical Oncology, Christie NHS Foundation Trust, and Division of Cancer Sciences, University of Manchester, Manchester (R.C.), and Guy's and St. Thomas' NHS Foundation Trust (S.G.) and Royal Marsden Hospital and the National Heart and Lung Institute, Imperial College London (S.P.), London - all in the United Kingdom; Virginia Cancer Specialists Research Institute and US Oncology Research, The Woodlands, TX (A.S.); Yale Cancer Center, New Haven, CT (S.N.G.); and Millennium Pharmaceuticals, Cambridge, MA (N.G., J.H., D.K.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1810171DOI Listing
November 2018

Patient selection for anti-PD-1/PD-L1 therapy in advanced non-small-cell lung cancer: implications for clinical practice.

Future Oncol 2018 Oct 6;14(23):2415-2431. Epub 2018 Jul 6.

Clatterbridge Cancer Centre, Liverpool Heart & Chest Hospital, University of Liverpool, Liverpool, UK.

View Article

Download full-text PDF

Source
https://www.futuremedicine.com/doi/10.2217/fon-2018-0330
Publisher Site
http://dx.doi.org/10.2217/fon-2018-0330DOI Listing
October 2018

An Evolving Algorithm to Select and Sequence Therapies in EGFR Mutation-positive NSCLC: A Strategic Approach.

Clin Lung Cancer 2018 01 8;19(1):42-50. Epub 2017 Jun 8.

UC Davis Comprehensive Cancer Center, Sacramento, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.05.019DOI Listing
January 2018

Osimertinib as First-Line Treatment in EGFR-Mutated Non-Small-Cell Lung Cancer.

Authors:
Sanjay Popat

N Engl J Med 2018 01;378(2):192-193

From the Department of Medicine, Royal Marsden Hospital, and the Section of Genomic Medicine, National Heart and Lung Institute, Imperial College, London.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMe1714580DOI Listing
January 2018

Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer.

Clin Lung Cancer 2017 11 14;18(6):595-606. Epub 2017 Mar 14.

Lung Unit, Royal Marsden Hospital, London, United Kingdom; National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London, United Kingdom; and the Institute of Cancer Research, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2017.03.002DOI Listing
November 2017

Nintedanib Plus Pemetrexed/Cisplatin in Patients With Malignant Pleural Mesothelioma: Phase II Results From the Randomized, Placebo-Controlled LUME-Meso Trial.

J Clin Oncol 2017 Nov 11;35(31):3591-3600. Epub 2017 Sep 11.

Federica Grosso, Azienda Ospedaliera SS Antonio e Biagio General Hospital, Alessandria; Silvia Novello and Giorgio Scagliotti, L'università di Torino, Azienda Sanitaria Ospedale San Luigi Gonzaga, Turin, Italy; Anna K. Nowak, University of Western Australia, Crawley, and Sir Charles Gairdner Hospital, Nedlands, Western Australia; Thomas John, Olivia Newton-John Cancer Research Institute, Austin Hospital, Heidelberg, Victoria, Australia; Sanjay Popat, The Royal Marsden Hospital National Health Service (NHS) Foundation Trust, London; Nicola Steele, The Beatson West of Scotland Cancer Centre, Glasgow; Paul Taylor, University Hospitals of South Manchester NHS Trust, Wythenshawe, Manchester, United Kingdom; Laurent Greillier, Assitance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille; David Planchard, Institut Gustave Roussy, Villejuif; Nassim Morsli, Boehringer Ingelheim France S.A.S., Paris, France; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Martin Reck, Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf; Ute von Wangenheim, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany; Jens Benn Sørensen, Rigshospitalet - Finsencentret, Copenhagen, Denmark; Mark A. Socinski, Florida Hospital Cancer Institute, Orlando, FL; Arsène Bienvenu Loembé, Boehringer Ingelheim B.V., Alkmaar, the Netherlands; and José Barrueco, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.9012DOI Listing
November 2017

Management of ceritinib therapy and adverse events in patients with ALK-rearranged non-small cell lung cancer.

Lung Cancer 2017 09 9;111:51-58. Epub 2017 Jun 9.

Royal Marsden Hospital, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.06.004DOI Listing
September 2017

Phase I clinical trials in patients with advanced non-small cell lung cancer treated within a Drug Development Unit: What have we learnt?

Lung Cancer 2017 09 15;111:6-11. Epub 2017 Jun 15.

Royal Marsden NHS Foundation Trust, London, United Kingdom; The Institute of Cancer Research, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.06.005DOI Listing
September 2017

Lack of response to nivolumab in a patient with EGFR-mutant non-small cell lung cancer adenocarcinoma sub-type transformed to small cell lung cancer.

Lung Cancer 2017 09 11;111:65-68. Epub 2017 Jul 11.

Lung Unit, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, United Kingdom; National Heart and Lung Institute, Imperial College London, Cale Street, London, SW3 6LY, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.07.012DOI Listing
September 2017

Novel insights into mesothelioma biology and implications for therapy.

Nat Rev Cancer 2017 07;17(8):475-488

University of Leicester, Leicester LE1 9HN, UK.

View Article

Download full-text PDF

Source
http://www.nature.com/doifinder/10.1038/nrc.2017.42
Publisher Site
http://dx.doi.org/10.1038/nrc.2017.42DOI Listing
July 2017

Targeting RET in Patients With RET-Rearranged Lung Cancers: Results From the Global, Multicenter RET Registry.

J Clin Oncol 2017 May 13;35(13):1403-1410. Epub 2017 Mar 13.

Oliver Gautschi, Kristin Zeidler, and Joachim Diebold, Lucerne Cantonal Hospital, Luzern; Patrizia Froesch, Ente Ospedaliero Cantonale, Bellinzona; Martin Früh, Kantonsspital St Gallen, St Gallen; Sacha I. Rothschild, University Hospital Basel, Basel, Switzerland; Julie Milia and Julien Mazières, Hôpital Larrey; Thomas Filleron, Institut Universitaire du Cancer, Claudius Regaud, Toulouse; Benjamin Besse and Jordi Remon-Masip, Institute Gustave Roussy, Villejuif; Gérard Zalcman, University Hospital Bichat, Paris; Isabelle Monnet, Centre Hospitalier Intercommunal de Creteil, Creteil; Florian Cabillic, Université de Rennes 1, Rennes, France; Juergen Wolf and Sebastian Michels, Center for Integrated Oncology, Cologne; Georg Pall, Fachkliniken Wangen, Wangen Im Allgäu; Arne Warth, Heidelberg University Hospital; Thomas Muley, Thoraxklinik at University of Heidelberg and Translational Lung Research Center, Heidelberg, Germany; David P. Carbone and Dwight Owen, Ohio State University Comprehensive Cancer Center, Columbus; Vamsidhar Velcheti, Cleveland Clinic, Pepper Pike, OH; Ross Camidge and Vignhesh Narayanan, University of Colorado, Denver; Robert C. Doebele, University of Colorado, Aurora, CO; Pasi A. Janne and Mark M. Awad, Dana-Farber Cancer Institute, Boston, MA; Daniel D. Karp, The University of Texas MD Anderson Cancer Center, Houston, TX; Heather A. Wakelee and Joel W. Neal, Stanford University, Stanford; Sai-Hong Ignatius Ou, University of California, Irvine, Orange; David R. Gandara and Jonathan W. Riess, University of California, Davis Cancer Center, Sacramento, CA; Alexander Drilon, Memorial Sloan Kettering Cancer Center, New York, NY; Nir Peled, Davidoff Cancer Center, Petach Tiqwa, Israël; Chul-Cho Byoung, Yonseï Cancer Center, Seoul, Republic of Korea; Michael Van Den Heuvel, Netherlands Cancer Institute, Amsterdam, the Netherlands; Tony S.K. Mok, The Chinese University of Hong Kong, Hong Kong, Special Administrative Region, People's Republic of China; James C.H. Yang and Jin-Yuan Shih, National Taiwan University Hospital, Taipei, Republic of China; Sanjay Popat, Royal Marsden Hospital, London, United Kingdom; and Rafael Rosell and Niki Karachaliou, Catalan Institute of Oncology, Barcelona, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.70.9352DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559893PMC
May 2017

Do Statins Improve Survival in Small-Cell Lung Cancer?

Authors:
Sanjay Popat

J Clin Oncol 2017 05 6;35(14):1497-1498. Epub 2017 Mar 6.

Sanjay Popat, Royal Marsden Hospital and Imperial College London, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2016.72.0870DOI Listing
May 2017

Crizotinib for ROS1 patients: One small step in biomarker testing, one giant leap for advanced NSCLC patients.

Lung Cancer 2017 02 11;104:131-133. Epub 2016 Nov 11.

Lung Unit, Royal Marsden Hospital, London SW3 6JJ, UK; National Heart & Lung Institute, Faculty of Medicine, Imperial College London, Guy Scadding Building, Cale Street, London SW3 6LY, UK; The Institute of Cancer Research, 123 Old Brompton Road, London SW7 3RP, UK.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002163052
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2016.11.007DOI Listing
February 2017

Continuing EGFR inhibition beyond progression in advanced non-small cell lung cancer.

Eur J Cancer 2017 01 17;70:12-21. Epub 2016 Nov 17.

Department of Medicine, Royal Marsden Hospital, London, UK; Section of Genomic Medicine, National Heart and Lung Institute, Imperial College, London, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.10.014DOI Listing
January 2017

Targeting MET Exon 14 Skipping Alterations: Has Lung Cancer MET Its Match?

J Thorac Oncol 2017 01;12(1):12-14

Royal Marsden Hospital, London, United Kingdom; National Heart and Lung Institute, Imperial College London, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.10.019DOI Listing
January 2017

Brain Metastases from NSCLC: Radiation Therapy in the Era of Targeted Therapies.

J Thorac Oncol 2016 10 23;11(10):1627-43. Epub 2016 Jun 23.

Radiotherapy Related Research, The Christie National Health Service Foundation Trust, Manchester, United Kingdom; Manchester Academic Health Science Centre, Institute of Cancer Sciences, Manchester Cancer Research Centre, The University of Manchester, Manchester, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.06.002DOI Listing
October 2016

A Validation Study for the Use of ROS1 Immunohistochemical Staining in Screening for ROS1 Translocations in Lung Cancer.

J Thorac Oncol 2016 07 11;11(7):1029-39. Epub 2016 May 11.

Department of Histopathology, Royal Brompton and Harefield National Health Service Foundation Trust, London, United Kingdom; National Heart and Lung Institute, Imperial College, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jtho.2016.03.019DOI Listing
July 2016

Development of molecularly targeted agents and immunotherapies in small cell lung cancer.

Eur J Cancer 2016 06 7;60:26-39. Epub 2016 Apr 7.

Lung Cancer Unit, Department of Medicine, Royal Marsden Hospital, London, United Kingdom; Division of Clinical Studies, The Institute of Cancer Research, London, United Kingdom. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.03.004DOI Listing
June 2016

Rationale for targeting the ErbB family of receptors in patients with advanced squamous cell carcinoma of the lung.

Future Oncol 2015 18;11(15):2175-91. Epub 2015 May 18.

Royal Marsden Hospital, London, UK.

View Article

Download full-text PDF

Source
April 2016

Eventual role of EGFR-tyrosine kinase inhibitors in early-stage non-small-cell lung cancer.

Future Oncol 2016 Mar 1;12(6):815-25. Epub 2016 Feb 1.

Lung Cancer Unit, Royal Marsden Hospital of London, London, SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.356DOI Listing
March 2016

A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients.

Cancer Chemother Pharmacol 2016 Feb 26;77(2):375-83. Epub 2015 Dec 26.

Department of Medicine, The Royal Marsden NHS Foundation Trust, Downs Road, Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-015-2950-1DOI Listing
February 2016

Problems of variable biomarker evaluation in stratified medicine research--A case study of ERCC1 in non-small-cell lung cancer.

Lung Cancer 2016 Feb 26;92:1-7. Epub 2015 Nov 26.

Cancer Research UK Clinical Trials Unit (CRCTU), MRC Midland Hub for Trials Methodology Research, Institute of Cancer and Genomic Sciences, University of Birmingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.11.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4729317PMC
February 2016

Response evaluation in mesothelioma: Beyond RECIST.

Lung Cancer 2015 Dec 22;90(3):433-41. Epub 2015 Aug 22.

EPSRC-CR UK Cancer Imaging Centre, Institute of Cancer Research, UK; Department of Radiology, Royal Marsden Hospital, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.08.012DOI Listing
December 2015

Nintedanib plus docetaxel as second-line therapy in patients with non-small-cell lung cancer: a network meta-analysis.

Future Oncol 2015 5;11(3):409-20. Epub 2014 Dec 5.

Department of Medicine (Lung), Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.14.290DOI Listing
November 2015

Systemic therapy for pulmonary carcinoids.

Lung Cancer 2015 Nov 12;90(2):139-47. Epub 2015 Sep 12.

Lung Unit, Royal Marsden Hospital, London SW3 6JJ, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2015.08.018DOI Listing
November 2015

Afatinib: a second-generation EGF receptor and ErbB tyrosine kinase inhibitor for the treatment of advanced non-small-cell lung cancer.

Future Oncol 2015 Sep 28;11(18):2525-40. Epub 2015 Aug 28.

Lung Unit, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/fon.15.183DOI Listing
September 2015

The efficacy of crizotinib in patients with ALK-positive nonsmall cell lung cancer.

Ther Adv Respir Dis 2015 Jun 22;9(3):97-104. Epub 2015 Mar 22.

Department of Medicine, Royal Marsden Hospital, Fulham Road, London, SW3 6JJ

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1753465815577738DOI Listing
June 2015

Never smoker with ground glass opacities on CT.

Lancet Respir Med 2015 Apr;3(4):328

Department of Medical Oncology, Royal Marsden Hospital, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S2213-2600(15)00035-1DOI Listing
April 2015

Resolution of severe hyponatraemia is associated with improved survival in patients with cancer.

BMC Cancer 2015 Mar 22;15:163. Epub 2015 Mar 22.

Department of Medicine, Royal Marsden NHS Foundation Trust, London, SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12885-015-1156-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381411PMC
March 2015

Toward precision medicine with next-generation EGFR inhibitors in non-small-cell lung cancer.

Pharmgenomics Pers Med 2014 19;7:285-95. Epub 2014 Sep 19.

Lung Cancer Unit, Department of Medicine, The Royal Marsden National Health Service Foundation Trust, London, United Kingdom ; National Heart and Lung Institute, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/PGPM.S55339DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178554PMC
October 2014

Afatinib in the treatment of EGFR mutation-positive NSCLC--a network meta-analysis.

Lung Cancer 2014 Aug 21;85(2):230-8. Epub 2014 May 21.

Instituto de Biomedicina de Sevilla - IBIS (University Hospital Virgen del Rocío, US, CSIC), Seville, Spain.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.05.007DOI Listing
August 2014

A comparison of immunohistochemical assays and FISH in detecting the ALK translocation in diagnostic histological and cytological lung tumor material.

J Thorac Oncol 2014 Jun;9(6):769-74

*Department of Histopathology, Royal Brompton and Harefield NHS Foundation Trust, London; †Centre for Molecular Pathology, The Royal Marsden Hospital, Sutton, Surrey; ‡Department of Oncology, The Royal Marsden Hospital; and §Department of Histopathology, Royal Marsden Hospital, Chelsea, London, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000157DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4132045PMC
June 2014

Patient reported outcomes from LUX-Lung 3: first-line afatinib is superior to chemotherapy-would patients agree?

Authors:
Sanjay Popat

Ann Palliat Med 2014 Jan;3(1):19-21

Department Medicine, Royal Marsden Hospital, London, SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://www.amepc.org/apm/article/view/3202
Publisher Site
http://dx.doi.org/10.3978/j.issn.2224-5820.2013.12.03DOI Listing
January 2014

The role of afatinib in the management of non-small cell lung carcinoma.

Expert Opin Drug Metab Toxicol 2013 Nov 28;9(11):1529-39. Epub 2013 Aug 28.

Royal Marsden NHS Foundation Trust , London , UK +44 20 7352 8171 ;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/17425255.2013.832755DOI Listing
November 2013

EGFR and KRAS mutations, and ALK fusions: current developments and personalized therapies for patients with advanced non-small-cell lung cancer.

Pharmacogenomics 2013 Nov;14(14):1765-77

Department of Medical Oncology, Portuguese Oncology Institute, Rua Dr António Bernardino de Almeida, 4200-072, Porto, Portugal.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/pgs.13.177DOI Listing
November 2013

A rare case of squamous cell carcinoma of the lung harbouring ALK and BRAF activating mutations.

Lung Cancer 2013 Jun 15;80(3):339-40. Epub 2013 Mar 15.

St Georges Healthcare NHS Trust, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.02.002DOI Listing
June 2013

What exactly are we doing to improve low lung cancer survival in the United Kingdom?

Thorax 2013 Jun 10;68(6):504-5. Epub 2013 Apr 10.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/thoraxjnl-2013-203543DOI Listing
June 2013

A pilot study of a novel home telemonitoring system for oncology patients receiving chemotherapy.

J Telemed Telecare 2013 Apr 23;19(3):148-152. Epub 2013 May 23.

Royal Marsden Hospital, NHS Foundation Trust, Downs Road, Sutton, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1357633X13483258DOI Listing
April 2013

Chemotherapy-induced bowel obstruction in small cell lung cancer: a case report.

Med Oncol 2012 Dec 28;29(4):2623-5. Epub 2011 Dec 28.

Royal Marsden Hospital NHS Foundation Trust, and Barts Cancer Institute, Queen Mary University of London, Fulham Road, London, SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12032-011-0150-3DOI Listing
December 2012

True hypoglycaemia secondary to treatment with granulocyte colony stimulating factor (G-CSF) in a diabetic patient with non-small cell lung cancer.

Lung Cancer 2012 Jan 27;75(1):133-5. Epub 2011 Nov 27.

Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2011.11.001DOI Listing
January 2012

Mismatch repair, minichromosome maintenance complex component 2, cyclin A, and transforming growth factor β receptor type II as prognostic factors for colorectal cancer: results of a 10-year prospective study using tissue microarray analysis.

Chin Med J (Engl) 2011 Feb;124(4):483-90

Department of Abdominal Surgical Oncology, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

View Article

Download full-text PDF

Source
February 2011

Supersensitive mutation: two case reports of non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.

Clin Lung Cancer 2010 Sep;11(5):E5-8

The Royal Marsden National Health Service Foundation Trust Sutton, Surrey, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/CLC.2010.n.047DOI Listing
September 2010

The combination of Young's syndrome and small cell lung cancer-A spiky connection?

Lung Cancer 2010 Mar 1;67(3):372-5. Epub 2009 Dec 1.

Royal Marsden Hospital, London, SW3 6JJ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2009.10.011DOI Listing
March 2010

Therapy Insight: anthracyclines and trastuzumab--the optimal management of cardiotoxic side effects.

Nat Clin Pract Oncol 2008 Jun 25;5(6):324-35. Epub 2008 Mar 25.

Royal Marsden Hospital and Imperial College, London, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncponc1090DOI Listing
June 2008

Time trends in the outcome of elderly patients with breast cancer.

Breast J 2008 Mar-Apr;14(2):158-63. Epub 2008 Feb 25.

The Royal Marsden Hospital, Surrey, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1524-4741.2007.00547.xDOI Listing
April 2008

Erlotinib, docetaxel, and gefitinib in sequential cohorts with relapsed non-small cell lung cancer.

Lung Cancer 2008 Feb 24;59(2):227-31. Epub 2007 Oct 24.

Department of Medicine, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2007.08.027DOI Listing
February 2008

Gut microflora associated characteristics in first-degree relatives of children with celiac disease.

Scand J Gastroenterol 2007 Oct;42(10):1204-8

Department of Microbiology, Tumor and Cell Biology, Karolinska Institute, Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/00365520701320687DOI Listing
October 2007

Malignant pleural mesothelioma: two cases in first degree relatives.

Lung Cancer 2007 Sep 2;57(3):407-9. Epub 2007 Apr 2.

Department of Medical Oncology, Royal Marsden Hospital, Sutton, SURREY SM2 5PT, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2007.02.005DOI Listing
September 2007

Recurrent responses to non-small cell lung cancer brain metastases with erlotinib.

Lung Cancer 2007 Apr 8;56(1):135-7. Epub 2006 Dec 8.

Department of Medicine, Royal Marsden Hospital, Sutton, Surrey SM2 5PT, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2006.11.009DOI Listing
April 2007

Relationship between chromosome 18q status and colorectal cancer prognosis: a prospective, blinded analysis of 280 patients.

Anticancer Res 2007 Jan-Feb;27(1B):627-33

Section of Cancer Genetics, Institute of Cancer Research, Sutton, UK.

View Article

Download full-text PDF

Source
April 2007

Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence.

Clin Cancer Res 2006 Nov;12(21):6585-9

Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom and Division of Epidemiology and Public Health, Medical School, Queen's Medical Centre, University of Nottingham, Nottingham, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-0903DOI Listing
November 2006

Palliative treatments for patients with inoperable gastroesophageal cancers.

Int J Palliat Nurs 2006 Jul;12(7):306-17

Kent Oncology Centre, Maidstone Hospital, Kent ME16 9QQ, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.12968/ijpn.2006.12.7.21606DOI Listing
July 2006

Re: Reporting recommendations for tumor marker prognostic studies (REMARK).

J Natl Cancer Inst 2005 Dec;97(24):1855; author reply 1855-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dji445DOI Listing
December 2005

Urethral polyp in neonate: a rare occurrence.

J Pediatr Surg 2005 Nov;40(11):e73-4

Department of Pediatrics, H.J. Doshi Sarvajanik Hospital and Medical Research Centre, Rajkot 360004 Gujarat, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpedsurg.2005.07.051DOI Listing
November 2005

A systematic review and meta-analysis of the relationship between chromosome 18q genotype, DCC status and colorectal cancer prognosis.

Eur J Cancer 2005 Sep;41(14):2060-70

Department of Medicine, Royal Marsden Hospital, London SW3 6JJ, United Kingdom.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S095980490500547
Publisher Site
http://dx.doi.org/10.1016/j.ejca.2005.04.039DOI Listing
September 2005

Re: Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis.

J Natl Cancer Inst 2005 Jun;97(11):858; author reply 858-9

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dji147DOI Listing
June 2005